Filing Flows › Milestone Scientific (MLSS) › Q2 2025
Milestone Scientific (MLSS) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 14, 2025
Milestone Scientific (MLSS) reported revenue of $2.3M for the second quarter 2025 (Q2 2025), +25% from a year earlier and +4% from the quarter before. Operating margin was -63.9%, net loss $1.5M (63.8% of revenue).
Milestone Scientific, Q2 2025: revenue $2.3M (+25% year over year), operating margin -63.9%, net loss $1.5M, operating cash flow −$1.8M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.3M | +4% | +25% |
| Operating profit | −$1.5M | — | — |
| Net earnings | −$1.5M | — | — |
| Operating cash flow | −$1.8M | — | — |
What changed
Revenue was $2.3M in Q2 2025, up 25% year over year and up 4% from the previous quarter.
Gross margin was 69.6%, down 6.5 points from a year earlier. Operating costs exceeded revenue by $1.5M, an operating margin of -63.9%. Operating expenses fell 3% while revenue rose 25%. The quarter ended with a net loss of $1.5M, narrower than the previous quarter's $2.0M loss.
Operating cash flow was −$1.8M. Non-cash charges added back $19K of depreciation and amortization and $160K of share-based compensation. Working capital and other items used $460K. Capital expenditures of $4K exceeded it, leaving free cash flow of −$1.8M.
Questions
What was Milestone Scientific's revenue in the second quarter 2025?
Milestone Scientific (MLSS) reported revenue of $2.3M for the second quarter 2025 (Q2 2025), +25% from a year earlier and +4% from the quarter before.
Was Milestone Scientific profitable in the second quarter 2025?
Operating loss was $1.5M (-63.9% of revenue) and net loss $1.5M.